Idiopathic Nephrotic Syndrome Clinical Trial
Official title:
Factors of Steroid Dependency in Idiopathic Nephrotic Syndrome
The primary purpose of the study is to identify the factors of steroid dependency in childhood idiopathic nephrotic syndrome. The steroid dependency is defined by a relapse of nephrotic syndrome within the 3 weeks that follow the withdrawal of steroid therapy after the first manifestation. Different clinical and biological factors will be analyzed: age of first manifestation, delay of remission, ethnicity, and preceding viral infection, geolocalization in the Parisian area, genoprevalence of herpes viruses and polymorphisms in the genes involved in the response to steroid therapy.
Patients with a steroid dependent nephrotic syndrome will be compared to those with a non steroid dependent form of nephrotic syndrome at the end of the first manifestation. An additional blood volume will be sampled in patients and controls during a scheduled biological check-up for the initial disease. Genetics factors will be checked using a DNA chips devoted to the response to steroid therapy and viral genome of EBV, CMV, HHV7 will be searched for using PCR reaction in total blood DNA extract. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01092962 -
Cyclophosphamide Versus Mycophenolate Mofetil for the Treatment of Steroid-dependent Nephrotic Syndrome in Children
|
Phase 3 | |
Recruiting |
NCT04075656 -
UrApp for Childhood Nephrotic Syndrome Management (Incident Cohort)
|
N/A | |
Recruiting |
NCT02896270 -
Valproic Acid for Idiopathic Nephrotic Syndrome
|
Phase 2/Phase 3 | |
Completed |
NCT04034316 -
Reduce Immunosuppression With Atmp in NS ChildrEn
|
Phase 2 | |
Completed |
NCT00255398 -
Kidney Disease Biomarkers
|
||
Recruiting |
NCT04207580 -
A National Prospective Cohort of Patients With Idiopathic Nephrotic Syndrome Beginning in Childhood.
|
||
Completed |
NCT04494438 -
Rituximab for Idiopathic Nephrotic Syndrome
|
Phase 3 | |
Active, not recruiting |
NCT01346007 -
Study of 7-valent Pneumococcal Conjugate Vaccine in Children With Idiopathic Nephrotic Syndrome
|
Phase 4 | |
Completed |
NCT04169776 -
Effect of Daily Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) on Proteinuria in Pediatric Patients With Idiopathic Nephrotic Syndrome
|
N/A | |
Recruiting |
NCT03298698 -
Efficacy of Rituximab in Comparison to Continued Corticosteroid Treatment in Idiopathic Nephrotic Syndrome
|
Phase 3 | |
Recruiting |
NCT03949972 -
The FOrMe Registry (The German Focal Segmental Glomerulosclerosis and Minimal Change Disease Registry)
|